Worsening of unrecognized tumour-induced osteomalacia with inadvertent use of recombinant human parathyroid hormone

Endokrynol Pol. 2020;71(1):102-103. doi: 10.5603/EP.a2019.0045. Epub 2019 Sep 30.

Abstract

Not required for Clinical Vignette.

Keywords: fragility fracture; hypophosphataemia; teriparatide; tumour-induced osteomalacia.

Publication types

  • Case Reports

MeSH terms

  • Bone and Bones / metabolism
  • Fractures, Stress / etiology
  • Hip Fractures / etiology
  • Humans
  • Male
  • Middle Aged
  • Muscle Weakness / etiology
  • Neoplasms, Connective Tissue / chemically induced
  • Neoplasms, Connective Tissue / diagnostic imaging*
  • Neoplasms, Connective Tissue / therapy*
  • Osteomalacia
  • Paraneoplastic Syndromes
  • Parathyroid Hormone / adverse effects*

Substances

  • Parathyroid Hormone

Supplementary concepts

  • Oncogenic osteomalacia